Primary results from FAIRLANE (NCT02301988), a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) plus paclitaxel (PAC) for early triple-negative breast cancer (eTNBC) Meeting Abstract
| Authors: | Oliveira, M.; Saura, C.; Calvo, I.; Andersen, J.; Coelho, J. L. P.; Gil, M. G.; Bermejo, B.; Patt, D. A.; Ciruelos, E.; Singel, S. M.; Maslyar, D. J.; Wongchenko, M.; Chan, W. Y.; Kapp, A. V.; de la Pena, L.; Baselga, J.; Isakoff, S. J. |
| Abstract Title: | Primary results from FAIRLANE (NCT02301988), a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) plus paclitaxel (PAC) for early triple-negative breast cancer (eTNBC) |
| Meeting Title: | 109th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 78 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2018 Apr 14-18 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2018-07-01 |
| Language: | English |
| ACCESSION: | WOS:000468818900039 |
| DOI: | 10.1158/1538-7445.Am2018-ct041 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: CT041 -- Source: Wos |
